| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AMED | Common Stock | Sale | -$511K | -5.91K | -58.66% | $86.43 | 4.16K | Mar 3, 2023 | Direct | F1, F2 |
| holding | AMED | Common Stock | 457 | Mar 3, 2023 | Through 401(k) Plan | F3 |
| Id | Content |
|---|---|
| F1 | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.05 to $87.01, inclusive. The reporting person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. |
| F2 | The total amount of shares beneficially owned includes 1,392 shares held in an employee stock purchase plan account. |
| F3 | The information in this report is based on a plan statement dated as of December 31, 2022. |